Cargando…
Reclassifying tumour cell cycle activity in terms of its tissue of origin
Genomic alterations resulting in loss of control over the cell cycle is a fundamental hallmark of human malignancies. Whilst pan-cancer studies have broadly assessed tumour genomics and their impact on oncogenic pathways, analyses taking the baseline signalling levels in normal tissue into account a...
Autores principales: | Lundberg, Arian, Yi, Joan Jong Jing, Lindström, Linda S., Tobin, Nicholas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392789/ https://www.ncbi.nlm.nih.gov/pubmed/35987928 http://dx.doi.org/10.1038/s41698-022-00302-7 |
Ejemplares similares
-
Reclassifying ovarian cancer: origins, subtypes and resistance to therapy
por: Bowtell, DDL
Publicado: (2012) -
Reclassifying stroke lesion anatomy
por: Bonkhoff, Anna K., et al.
Publicado: (2021) -
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours
por: Lundberg, Arian, et al.
Publicado: (2019) -
Codeine-containing medicines to be reclassified in NZ
Publicado: (2020) -
Need to reclassify keratocystic odontogenic tumor into cyst and neoplasm
por: Singh, Harkanwal Preet
Publicado: (2016)